| Status: Excluded due to NICE appraisal | |
Product meets AWMSG exclusion criteria due to NICE appraisal TA882: Voclosporin with mycophenolate mofetil for treating lupus nephritis |
|
Medicine details |
|
| Medicine name | voclosporin (Lupkynis®) |
| Formulation | oral formulation |
| Reference number | 2984 |
| Indication | In combination with mycophenolate mofetil for the treatment of adult patients with active class III, IV or V (including mixed class III/V and IV/V) lupus nephritis |
| Company | Aurinia Pharmaceuticals |
| BNF chapter | Malignant disease & immunosuppression |
| Assessment type | N/A |
| Status | Excluded due to NICE appraisal |
| Date of issue | 30/09/2022 |
| NICE guidance | TA882: Voclosporin with mycophenolate mofetil for treating lupus nephritis |